CRITICAL ASPECT ANALYTICAL TEST REVIEW
|
|
- Tamsin Sharp
- 6 years ago
- Views:
Transcription
1 CRITICAL ASPECT ANALYTICAL TEST REVIEW Jakarta 14 December 2017 Speaker: HERU PURNOMO, ST
2 QC WORK FLOW Start Sample Received (In-Process & Finished Good) Testing Review Lab Result Yes No Non Conformance or Out of Specification Investigation Meet Specification Submission Lab Record to QA BATCH DISPOSITION Stop Connecting Pharmaceutical Knowledge ispe.org 2
3 Analytical Test Result Analytical Worksheet Analytical Report Certificate of Analysis (CoA) Internal document to be used by the analyst for recording information about the sample, the test procedure, calculations and the results of testing. It is to be complemented by the raw data obtained in the analysis The analytical test report is a compilation of the results and states the conclusions of the examination of a sample The list of test procedures applied to a particular sample with the results obtained and the acceptance criteria applied. It indicates whether or not the sample complies with the specification Connecting Pharmaceutical Knowledge ispe.org 3
4 Certificate of Analysis (CoA) A specification is defined as a list of tests, references to analytical procedures, and appropriate acceptance criteria that are numerical limits, ranges, or other criteria for the tests described It establishes the set of criteria to which a drug substance or drug product should conform to be considered acceptable for its intended use. Conformance to specifications means that the drug substance and/or drug product, when tested according to the listed analytical procedures, will meet the listed acceptance criteria Connecting Pharmaceutical Knowledge ispe.org 4
5 Review of Analytical Test Result Written procedure should be in place when reviewing analytical result with the following information: Provide general guideline for checking of analytical raw data, worksheet and associated document in QC Lab Applies to GMP analytical raw data in physical chemical, microbiology and raw material Preparation steps, observation and calculation step should be documented and show on the worksheet, these associated documentations have to be reviewed for completeness and accuracy as well The date of execution and analyst / chemist / microbiologist who perform the testing is to be identified on worksheet All printout of raw data should be attached to the analytical worksheet. Printout must signed or initialled across the edge of attachment Connecting Pharmaceutical Knowledge ispe.org 5
6 HPLC / GC Chromatographic Test The following review for chromatographic data should be done for completeness and accuracy: 1. Program setup: Flow rate, detector wavelength, column temperature, mobile phase (e.g. isocratic / gradient) & composition, need wash / seal wash setup 2. Sequence Setup Injection Volume, Column ID, Sample Type, Sample Description, Sample Weight, Reference accuracy weight 3. Integration Setup SST Setup, Reference Standard Weight Entry, retention setup and allowable window, proper integration peak 4. Chromatogram Examine the blank chromatogram and note any extra peaks, particularly those that co-eluate with any peak interest 5. Audit trail Check data integrity of sequence by verifying the audit trail for any unauthorized changes Connecting Pharmaceutical Knowledge ispe.org 6
7 HPLC / GC Chromatographic Test (cont) 6. Check the expiry of standard and test mix, use in the analysis, against the relevant reference material certificate or preparation. Ensure they are within the expiry date and preparation correct 7. Check that specified system suitability result are met against the relevant testing method 8. Check the accuracy of all values that are manually calculated Connecting Pharmaceutical Knowledge ispe.org 7
8 Dissolution Check should be carried out on both the dissolution procedure and method analysis: 1. Dissolution medium used and the operating temperature 2. Type of Aparatus 3. Preparation standard and sample 4. Sampling procedure and technique (e.g. intervals, filtration, handling of samples, dilution) 5. Calculations 6. The blank and standard solution spectra or chromatograms supporting the dissolution test should either be available electronically or documented in lab worksheet Connecting Pharmaceutical Knowledge ispe.org 8
9 Microbiological Testing for Water, Environment Monitoring (EM), Microbial Limit Test (MLT) 1. Check that the analytical worksheet and SOP used were correct and the sampling points were accurately recorded. Check the presence and accuracy of the following minimum information: Date of sampling / performed date of testing Date of reading plate / result recording date Indicate the lot reference and expiry date of media used and verified that the lot reference used is within expiry date at point of usage Date and temperature of incubation Equipment ID and ensure equipment are still within their qualification / calibration status at point of usage Test result of negative or positive control which was carried out in accordance to the test method Water sampling point (for microbiological testing for water) / legend (for environment monitoring) Initial of analyst & reviewer and date 2. Check the result against the acceptance criteria in the relevant test procedure Connecting Pharmaceutical Knowledge ispe.org 9
10 Other Tests Hard copy, generated from test (for example: UV, infrared absorption) should bear the following information: Initial / name of analyst Sample Identity Instrument Number Spectrum (where applicable) Testing date Instrument Parameter (where applicable) Result / data obtained Connecting Pharmaceutical Knowledge ispe.org 10
11 Tolerance Limit & Specification Check If the test method requires tolerance limit check for the replicate runs, check the replicate value against the pre-defined tolerance limit in the test method Check the reported results against specification and trend limit (if any) The review period of a GMP analytical result should be recorded in a timely manner (e.g. 24 working hours from the test completion date) Connecting Pharmaceutical Knowledge ispe.org 11
12 Trend Rule Violation Out of Trend There are three (3) trend rule violations: 1. Result out of trend limits 2. Nine (9) or more consecutive data points shifted above or below the center line 3. Six (6) or more data points consecutively increasing or decreasing Connecting Pharmaceutical Knowledge ispe.org 12
13 OUT OF TREND (OOT) - NELSON TEST Rule # 1 Any point outside control limit Rule # 2 9 consecutive point on same side centreline Rule # 3 6 consecutive point decreasing or increasing Connecting Pharmaceutical Knowledge ispe.org 13
14 What is an Audit Trail? 1. Systematic story of the data from creation, through interpretation and final assessment and report 2. Each functional area that have GxP computer systems need to perform audit trail 3. The information should be recorded in Audit Trail: Date and Time Name of person making change Original Change and value Reason of change made Invalid attempts to log on the system If audit trail procedure is not available, the company has no possibility to detect violations to data integrity executed by site Operators due to errors / malfeasances, unintended or deliberate Connecting Pharmaceutical Knowledge ispe.org 14
15 Regulatory Guidance for Audit Trail Review Connecting Pharmaceutical Knowledge ispe.org 15
16 Audit Trail Review Evaluation of process risk associated to the system intended use An assessment must be performed for each system in order to identify the most adequate method Connecting Pharmaceutical Knowledge ispe.org 16
17 Audit Trail Review Risk class identification to define critical point: Frequency of audit trail Sampling Plan: The number of record to be reviewed Connecting Pharmaceutical Knowledge ispe.org 17
18 Audit Trail Review Create form to define the verification to be executed and the relevant acceptance criteria Connecting Pharmaceutical Knowledge ispe.org 18
19 Common Question During Inspection Is the audit trail activated? SOP? Record of review? How to prevent or detect any deletion of modification of audit trail data? Training staff? Is predicate rule principle followed for changed? Preserve of original data Corrected data Date of correction Name of person who correction the data Justification comment for correction What if there is no audit trail function? Can you prove data manipulation did not occur? Connecting Pharmaceutical Knowledge ispe.org 19
20 Connecting Pharmaceutical Knowledge ispe.org 20
21 Connecting Pharmaceutical Knowledge ispe.org 21
22 QA Responsibility Do I need to review Analytical test result? System & Facility Create robust procedure to review analytical test result Qualified personnel Allocate budget to reduce potential data integrity issue Culture Develop management practises and supervision to encourage reporting problem Identify root causes without finger pointing Confident Random check based on risk assessment approach Connecting Pharmaceutical Knowledge ispe.org 22
23 Connecting Pharmaceutical Knowledge ispe.org
24 Connecting Pharmaceutical Knowledge ispe.org
Inspection of Quality Control Laboratories
Inspection of Quality Control Laboratories PQP Manufacturer's Meeting April 4-5 th 2011, Geneva, Switzerland Stephanie Croft, M.Sc. Technical Officer (Inspector), WHO Prequalification of Medicines Programme
More informationLessons from Pharmaceutical Laboratory related FDA Warning Letters
Lessons from Pharmaceutical Laboratory related FDA Warning Letters The Agilent Critical Compliance Seminar 2016 Ludwig Huber Ludwig_huber@labcompliance.com Overview FDA Inspections and reports GMP compliance
More informationWelcome to our E-Seminar: Automation Tools for Efficient Result Review According to GMP
Welcome to our E-Seminar: Automation Tools for Efficient Result Review According to GMP Overview Overview Chapter Page Overview The sample lifecycle 6 Chromatographic data system and the sample life cycle
More informationCOMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance
More informationEnsure Data Integrity Compliance Enterprise-Wide
Ensure Data Integrity Compliance Enterprise-Wide PharmaQual 360 º Conference February 24, 2017 Chris Wubbolt QACV Consulting, LLC www.qacvconsulting.com 1 Objectives What is data integrity and the definition
More informationPAI Inspections, Observations and Data Integrity
PAI Inspections, Observations and Data Integrity Krishna Ghosh, Ph.D. Office of Pharmaceutical Quality Office of Process and Facilities Center for Drug Evaluation and Research November, 2017 20 November
More informationValidation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals.
Validation of Analytical Methods used for the Characterization, Physicochemical and Functional Analysis and of Biopharmaceuticals. 1 Analytical Method Validation: 1..1 Philosophy: Method validation is
More informationRegulatory Expectations, Standards & Guidelines
Regulatory Expectations, Standards & Guidelines Regulatory Requirements Pharmacopeias Good Automated Manufacturing Practice (GAMP) 21 CFR Part 11 and Annex 11 Consequences of Non-Compliance 22 Regulatory
More informationContents. Contents (13) 1 Production (23)
1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 6 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Aarti Drugs Limited
More informationWHO PUBLIC INSPECTION REPORT (WHOPIR) Quality Control Laboratory. Uganda (NDQCL-NDA) Mulago Hill, P.O. Box 23096, Kampala, Uganda. NDA,
SOP 408.4 Annex D 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int WHO PUBLIC INSPECTION REPORT (WHOPIR) Quality Control Laboratory Part
More informationISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua
ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER 7 2016 TUUSULA FINLAND Timo Kuosmanen STERIS Finn-Aqua Timo_Kuosmanen@steris.com AUDIT TRAIL IN CRITICAL UTILITIES MONITORING CURRENT TRENDS CONTENTS BACKGROUND
More informationCERTIFIED MAIL RETURN RECEIPT REQUESTED
Department of Health and Human Services Public Health Service Food and Drug Administration Warning Letter WL: 320-14-11 CERTIFIED MAIL RETURN RECEIPT REQUESTED June 16, 2014 Jeremy B. Desai, PhD President
More informationPURITAN PRODUCTS QUALITY OVERVIEW. Quality Management System Self-Audit. September 15, 2015
PURITAN PRODUCTS QUALITY OVERVIEW Quality Management System Self-Audit September 15, 2015 Founded in 1987, Puritan Products, Inc. is a cgmp compliant, FDA registered and inspected, and ISO-9001:2008 certified
More informationEnsure Data Integrity Compliance in the Analytical Laboratory A Life Cycle Approach
Ensure Data Integrity Compliance in the Analytical Laboratory A Life Cycle Approach Paresh Patel Director, Scientific Operations Johnson& Johnson QS&S 12/14/2016 1 1 Topics GMP regulatory requirements
More informationStandard Operating Procedure Title: Initial Investigation of Out of Specification (OOS) Results in Microbiological Laboratory
Department Micro Laboratory Document no MICLAB 145 Title 1.0 DOCUMENT OWNER Laboratory/Quality Manager 2.0 PURPOSE To establish a procedure for the investigation of initial out-of-specification (OOS) or
More informationISPE-FDA 3 rd Annual CGMP Conference 2 4 June 2014 Baltimore, MD. Detecting GMP Data Integrity Issues
Detecting GMP Data Integrity Issues Elaine Eborall Senior Director, GMP Compliance, Americas and Asia Pacific Compliance and External Collaboration ISPE-FDA cgmp Conference Baltimore, Maryland 2-4 June
More informationBATCH DISPOSITION BATCH DISPOSITION REGULATION. Jakarta 14 DECEMBER Speaker: MIMI VIRLANY SYAHPUTRI, M.Sc., S.si., APT
BATCH DISPOSITION REGULATION Jakarta 14 DECEMBER 2017 Speaker: MIMI VIRLANY SYAHPUTRI, M.Sc., S.si., APT Definition Batch disposition = product disposition = lot disposition The documented control, status
More informationá1225ñ VALIDATION OF COMPENDIAL PROCEDURES
1640 á1224ñ Transfer of Analytical Procedures / General Information USP 39 THE ANALYTICAL PROCEDURE The procedure should be written with sufficient detail and explicit instructions, so that a trained analyst
More information21CFR Ventilation, air filtration, air heating and cooling. 21CFR211 Details, Details. 21CFR Equipment Cleaning and Maintenance
21CFR211 Details, Details Kirsten L. Vadheim, Ph.D., RAC 7710 196th Avenue N.E. Redmond WA 98053 Tel: 651.260.6560 Fax: 425.868.4302 klvadheim@hotmail.com 21CFR211.46 Ventilation, air filtration, air heating
More informationInspection Trends. American Society for Quality Richmond, VA Section March 8, 2016
Inspection Trends American Society for Quality Richmond, VA Section March 8, 2016 Brooke K. Higgins, Senior Policy Advisor CDER / Office of Compliance Office of Manufacturing Quality Division of Drug Quality
More informationGUIDANCE NOTES ON ANALYTICAL METHOD VALIDATION
ON ANALYTICAL METHOD VALIDATION HSA September 2004 Reproduction prohibited for commercial purposes. Reproduction for internal use is authorised, provided the source is acknowledged. MQA Dir: DISK1\GUIDE-MQA-012A-004.doc
More informationDocument Review 1 2 3
01 DOCUMENT CONTROL 01 4.3 The current authorized test method and (7.2.1.2) supporting work instructions are available to the analyst. 02 01 5.4 (7.2.1.5) TEST METHOD VERIFICATION/VALIDATION For standard
More informationOut of Specification & Out of Trend Investigations. October 2017
Out of Specification & Out of Trend Investigations October 2017 How to use the Investigation Flowchart Navigation: Clicking on those Process Step boxes with a heavy border in a process flow will take you
More informationBeamex CMX Calibration Software and GAMP - Good Automated Manufacturing Practices
Beamex CMX Calibration Software and GAMP - Good Automated Manufacturing Practices GAMP Good Automated Manufacturing Practices The GAMP Forum was established in 1991 to help promote the understanding of
More informationPublic Health Service Food and Drug Administration Silver Spring, MD WARNING LETTER VIA UPS WL:
Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993 WARNING LETTER VIA UPS WL: 320-16-04 December 17, 2015 Mr. Avinash Joshi Quality Head
More informationSun Pharmaceutical Industries Ltd. 12/17/15
1 of 7 02/18/2016 11:34 AM U.S. Food and Drug Administration Protecting and Promoting Your Health Sun Pharmaceutical Industries Ltd. 12/17/15 Department of Health and Human Services Public Health Service
More informationPublic Health Service Food and Drug Administration Silver Spring, MD WARNING LETTER VIA UPS WL: December 17, 2015
12/23/2015 1:37 PM 1 of 10 U.S. Food and Drug Administration Protecting and Promoting Your Health Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring,
More informationIDT Australia Ltd. 5/23/18
IDT Australia Ltd. 5/23/18 10903 New Hampshire Avenue Silver Spring, MD 20993 Via UPS Warning Letter 320-18-55 Return Receipt Requested May 23, 2018 Dr. Graeme R. Kaufman CEO, Acting, and Chairman of the
More informationGOOD CHROMOTOGRAPHY PRACTICES (February 2019) DRAFT FOR COMMENTS
February 2019 Draft document for comments 1 2 3 4 GOOD CHROMOTOGRAPHY PRACTICES (February 2019) DRAFT FOR COMMENTS Please send any comments you may have to Dr S. Kopp, Group Lead, Medicines Quality Assurance,
More informationPage 1 of 5 Home Inspections, Compliance, Enforcement, and Criminal Investigations Compliance Actions and Activities Warning Letters 2014 Inspections, Compliance, Enforcement, and Criminal Investigations
More informationCUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)
21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software
More informationThe procurement, qualification and calibration of lab instruments: An Overview
The procurement, qualification and calibration of lab instruments: An Overview The reliability of analytical data generated from chemical and physical analyses is critically dependent on three factors:
More informationIncremental GMPs. Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, PCI Pharmaceutical Consulting Israel Ltd.
Incremental GMPs Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, 2017 1/55 Sound Science Good Development Practice Traceability R&D Tox I II III IV What You Need Here Can t be generated here
More informationAutomating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper
Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper Varian, Inc. 2700 Mitchell Drive Walnut Creek, California 94598, USA www.varianinc.com Introduction Chromatographic
More informationUSP Chapter 823 USP 32 (old) vs. USP 35 (new)
USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has
More informationIntroduction to 21 CFR 11 - Good Electronic Records Management
INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Review Article Introduction to 21 CFR 11 - Good Electronic Records Management Pal Tapas Kumar* and Maity Subhasis NSHM Knowledge Campus,
More informationMahendra Chemicals 7/13/15
Mahendra Chemicals 7/13/15 Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993 CERTIFIED MAIL RETURN RECEIPT REQUESTED July 13, 2015 Mr. Rajnibhai
More informationAutomating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper
Automating HPLC and GC Analytical Method Validation Fusion AE Software Program White Paper S-Matrix Corporation 1594 Myrtle Avenue Eureka, CA 95501, USA www.smatrix.com Introduction Chromatographic analytical
More informationWHO PUBLIC INSPECTION REPORT (WHOPIR) Quality Control Laboratory
SOP 408.4 Annex D 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int WHO PUBLIC INSPECTION REPORT (WHOPIR) Quality Control Laboratory Part
More informationDrug Good Manufacturing Practices Inspections
Drug Good Manufacturing Practices Inspections New England District Investigations Branch Parenteral Drug Association New England Chapter May 17, 2006 DRUG MANUFACTURING INSPECTIONS Inspections Include:
More informationMass Detection for the Chromatographer Waters ACQUITY QDa Detector
Mass Detection for the Chromatographer Waters ACQUITY QDa Detector Warren B Potts III Senior Director Americas Marketing warren_potts@waters.com 2017 Waters Corporation 1 Agenda Overview of technology
More informationClarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation
Clarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation Datasheet Introduction US Part 11 in Title 21 of Code
More informationfor IND and RDRC Regulated PET Compounding
Overview of USP Chapter for IND and RDRC Regulated PET Compounding Distributed Manufacturing of PET Radiopharmaceuticals for Multi-Center Clinical Trials SNM, Annual Meeting Toronto, Ontario, Canada
More informationA2LA. R231 Specific Requirements: Threat Agent Testing Laboratory Accreditation Program. December 6, 2017
Laboratory Page 1 of 17 Laboratory December 6, 2017 2017 by A2LA All rights reserved. No part of this document may be reproduced in any form or by any means without the prior written permission of A2LA.
More informationGood manufacturing practices
ORIGINAL PAPER 1AR-10 ISBT Science Series (2009) 4, 6 10 Journal compilation 2009 International Society of Blood Transfusion Good manufacturing practices Blackwell Publishing Ltd A. Ahmed Quality Manager,
More informationPrequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer
Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.
More informationFibonacci Sequences Improve GAMP 5 Risk Assessment for GLP Computerized Systems
WHITE PAPER Analyst Software Validation Service Fibonacci Sequences Improve GAMP 5 Risk Assessment for GLP Computerized Systems S. D. Nelson, Blair James, Patrick Quinn-Paquet, Justyna Sekula, Dave Abramowitz
More informationData Integrity Issues & Concerns PDA Meeting Kansas City, MO August 21, 2017
Data Integrity Issues & Concerns PDA Meeting Kansas City, MO August 21, 2017 CAPT Sharon K. Pederson (Thoma), PharmD National Expert of Pharmaceutical Inspections Food and Drug Administration ORA/OMPTO/OPQO/DPQP/Pharmaceutical
More informationTNI s NATIONAL ENVIRONMENTAL LABORATORY ACCREDITATION PROGRAM (NELAP) Changing to the 2009 Standard
TNI s NATIONAL ENVIRONMENTAL LABORATORY ACCREDITATION PROGRAM (NELAP) Changing to the 2009 Standard THE NEW NELAP STANDARDS Four Volumes = Four Standards Volume 1: Requirements for Laboratories 7 Modules
More informationData Integrity Compliance Project
Data Integrity Compliance Project RISK FACTORS FOR DI ISSUES Outsourcing Supply Chain Data Review Practices Increasing use of electronic systems Economic Stressors 2 Fully Integrated into QMS DATA INTEGRITY
More informationRAJESH NAIR DIRECTOR CALF-NDDB, ANAND, GUJARAT
RAJESH NAIR DIRECTOR CALF-NDDB, ANAND, GUJARAT 1 Coverage Need of AQC in food testing laboratories Analytical quality system of food testing laboratories Relationship between Quality System, Quality Assurance
More informationSTANDARD OPERATING PROCEDURES. Handling and working with Analytical Standards
Page: 1 of 6 1.Purpose The purpose of this Standard Operating Procedure is to establish a standardized procedure of using United States Pharmacopoeia (USP) standards, detailing the procedure of qualification,
More informationCould Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it.
1 How to Meet New MHRA, FDA and WHO Data Integrity Guidelines WHITE PAPER Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it. 2 How to
More informationNew Data Integrity Regulations and Practical Advice for Life Science Laboratories. we prove it.
1 How to Meet New MHRA, FDA, EMA and WHO Data Integrity Guidelines white paper New Data Integrity Regulations and Practical Advice for Life Science Laboratories we prove it. 2 How to Avoid Poor Temperature
More informationDocumenta tion and Records
Documenta tion and Records Page 1 of 30 Training Outcome of the Module: After completing this module, you will be able to: Recognize the importance of procedures Recognize the importance of record keeping
More informationInterpharm Praha A.S. 10/18/16
Interpharm Praha A.S. 10/18/16 Department of Health and Human Services Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 Via UPS Return Receipt Requested
More informationQUALITY AGREEMENT. The following Agreement has been concluded between
QUALITY AGREEMENT The following Agreement has been concluded between LLC LABORATORIES The contract laboratory and service provider 1625 Trinity Dr., Unit 11 Mississauga, Ontario Canada L5T 1W9 Hereinafter
More informationStrategies for Risk Based Validation of Laboratory Systems
Strategies for Risk Based Validation of Laboratory Systems Video Web Seminar September 23, 2004 Ludwig Huber E-mail: ludwig_huber@agilent.com Today s Agenda Background information: why risk assessment,
More informationMedicines inspections technical updates: Contract research organizations (CROs)
JOINT UNICEF, UNFPA & WHO MEETING WITH MANUFACTURERS AND SUPPLIERS OF CONTRACEPTIVE DEVICES, IN VITRO DIAGNOSTICS PRODUCTS, VACCINES, FINISHED PHARMACEUTICAL PRODUCTS, ACTIVE PHARMACEUTICAL INGREDIENTS
More informationGMP On Site Series. GMP Essentials
GMP On Site Series GMP Essentials GMP Basics Objectives 1. State the critical definitions of the pharmaceutical industry. 2. Describe the law as it applies to various critical functions. 3. State the history
More informationManual Analytical Data Adjustment. Environmental Health Laboratories A division of MAS Technology Corporation
Corporate Policy for Quality Assurance Manual Analytical Data Adjustment Environmental Health Laboratories A division of MAS Technology Corporation 110 S. Hill Street South Bend, IN 46617 Phone: (219)
More information3. Equipment Cleaning Validation for Active Pharmaceutical Ingredients (APIs) 8. Process Validation for Active Pharmaceutical Ingredients (API)
Title: Good Working Practice Validation Requirements Practice Number: 06 Prepared by: Date: Supersedes: Checked by: Date: Date Issued: Approved by: Date: Review Date: Topics: 1. Biological Test Methods
More informationInspections, Compliance, Enforcement, and Criminal Investigations
1 of 7 6/10/2009 12:50 PM Inspections, Compliance, Enforcement, and Criminal Investigations Department of Health and Human Services Public Health Service Food and Drug Administration Central Region Waterview
More informationAdopted by GCP Inspectors Working Group (GCP IWG) 29 November 2017
13 June 2017 EMA/431270/2016 Annex VII to guidance for the conduct of good clinical practice inspections bioanalytical part, pharmacokinetic and statistical analyses of bioequivalence trials Adopted by
More information[ WHITE PAPER ] A Basic Overview: Meeting the PIC/S Requirements for a Computerized System INTRODUCTION GOOD MANUFACTURING PRACTICES
A Basic Overview: Meeting the PIC/S Requirements for a Computerized System Lynn Archambault Waters Corporation, Milford, MA, USA INTRODUCTION The Pharmaceutical Inspection Convention and Pharmaceutical
More informationChemical Aspects of Stability Evaluation
Chemical Aspects of Stability Evaluation 8 steps to generating stability data which speaks for itself Alan Doughty Chief Chemist Pty Ltd Aim of a stability trial Obtain data which allows a definitive conclusion
More informationGuidance for Industry
Guidance for Industry Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
More informationLEGAL REQUIREMENTS FOR STABILITY
BY DR. A.V.PRABHU LEGAL REQUIREMENTS FOR STABILITY 21 CFR 211.166- STABILITY TESTING GMP To assess stability characteristics to determine storage conditions and expiration dates. Written stability program
More informationImpurity Control in the European Pharmacopoeia
Impurity Control in the European Pharmacopoeia Training Session Zagreb, Croatia, 24-25 May, 2018 Dr Ulrich Rose Head of Division European Pharmacopoeia Department, EDQM Agenda Which impurities are controlled?
More informationWARNING LETTER AUG 3, 2016
Ropack, Inc. 8/3/16 Department of Health and Human Services Public Health Service Food and Drug Administration 10903 New Hampshire Avenue White Oak Building 66 Silver Spring, MD 20993 WARNING LETTER AUG
More informationDrug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel
Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active
More informationSubpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.
FDA inspections continue to focus on CGMP violations related to basic GMP controls. A survey of Warning Letters issued in 2013 on CMC (Chemistry / Manufacturing / Controls) violations reveals an emphasis
More informationINVESTIGATE OOT AND OOS IN STABILITY STUDIES
INVESTIGATE OOT AND OOS IN STABILITY STUDIES Kim Huynh-Ba Executive Director Pharmalytik LLC www.pharmalytik.com BIOGRAPHY Kim Huynh-Ba has over 25 years of experience in analytical development, project
More informationManual 058 Out of Specification Results Investigation
1 Purpose The purpose of this Guideline is to provide guidance for the investigation and response to Out of Specification (OOS) laboratory test results. 2 Scope and Applicability This Guideline applies
More informationApplication Note. Author. Abstract. Pharmaceuticals. Detlef Wilhelm ANATOX GmbH & Co. KG. Fuerstenwalde, Germany mau
Development, validation, and comparison of an HPLC method to analyze paracetamol and related impurities according to the European Pharmacopoeia (EP) and USP using the Agilent 1120 Compact LC and the Agilent
More informationICH Q2(R1) A Primer. cgmp. GxP PIC/S SOP ISO QA/QC LOD/LOQ. Validation of Analytical Methods API EP FDA OECD GCP
USP ICH Q2(R1) A Primer GxP cgmp PIC/S SOP ISO 17025 QA/QC LOD/LOQ API EP Validation of Analytical Methods FDA OECD GCP Validation of Analytical Methods Ludwig Huber Contents Preface...............................................
More informationPrequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer
Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer PART 1: GENERAL INFORMATION Name of Manufacturer Calyx Chemicals & Pharmaceuticals Ltd Unit:
More informationOverview of a sterility assurance program for PET drugs
Coalition for PET Drug Approval Radiopharmaceutical Sciences Council Overview of a sterility assurance program for PET drugs Eric Webster, PETNET Solutions Disclosures Employee of PETNET Solutions, a Siemens
More informationA24 CALA Checklist for Microbiology Revision 4.1 February 16, 2018
A24 CALA Checklist for Microbiology Revision 4.1 February 16, 2018 Laboratory Name: Appendix Name: Appendix Number: Assessor: Date: Rev. 4.1 CALA CHECKLIST FOR MICROBIOLOGY Item 01 SAMPLING AND SAMPLE
More informationOverview of Good Food Laboratory Practices
Overview of Good Food Laboratory Practices Dr. Anne Bridges Technical Director, AACC International International Workshop & Training Program On Good Food Laboratory Practices Jointly Organized By Food
More informationPharmaceutical Reference Standards: Overview and Role in Global Harmonization
Matthew Borer, Ph.D., Advisor Pharmaceutical Reference Standards: Overview and Role in Global Harmonization 3rd DIA China Annual Meeting Beijing, China, 16-18 May, 2011 What is a Pharmaceutical Reference
More informationEquipment cleaning and use record
DOCUMENTATION Documentation is an essential part of the quality assurance system and, as such, should be related to all aspects of GMP. Its aim is to define the specifications for all materials and the
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 5 Inspections, Compliance, Enforcement, and Criminal Investigations Hill Dermaceuticals, Inc. Department of Health and Human Services Public Health Service Food and Drug Administration Food and
More informationQuality Manual. Index
This quality policy manual is for the use of, its Clients, Vendors, and the appropriate Regulatory Agencies. Unauthorized duplication or transfer to others is prohibited. Index Authorization... 3 Introduction...
More informationOvercome the Top Challenges of Handling OOS Results by Knowing FDA Observations
Overcome the Top Challenges of Handling OOS Results by Knowing FDA Observations Jerry Lanese Ph.D. The Lanese Group, Inc. 2015 The Lanese Group, Inc. 1 Who decided you should come to this conference? On
More informationLABORATORY COMPLIANCE
1 LABORATORY COMPLIANCE Jeanne Moldenhauer Vectech Pharmaceutical Consultants, Inc. Farmington Hills, MI INTRODUCTION Implementation of the Systems-Based Inspection Guideline for drug manufacturers in
More informationGuidelines for Process Validation of Pharmaceutical Dosage Forms
Guidelines for Process Validation of Pharmaceutical Dosage Forms Version 2.1 Date issued 21/02/2010 Date of implementation 21/05/2010 31 August 2010 Page 1 of 20 Guidelines for Process Validation of Pharmaceutical
More informationQUALITY SYSTEM MANUAL
QUALITY SYSTEM MANUAL This Manual is a Proprietary Document and any Unauthorized Reproduction is prohibited. ISSUE DATE July 26, 2012 AUTHORIZED BY: Quality Management Representative Eric Hoff Managing
More informationGUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY
GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY 2017 GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY 2017 Copyright 2017 by British Compressed Gases Association. First printed 2017. All rights reserved. No
More informationRegistered Starting Material Auditing Guide
Registered Starting Material Auditing Guide Annex 1 Aide Mémoire Company : Auditor(s) : Location, Country : Date of Audit: APIC Guide for Auditing Registered Starting Material Manufacturers Remark: Non-compliance
More informationVALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY *)
VALIDATION OF ANALYTICAL PROCEDURES: METHODOLOGY *) Guideline Title Validation of Analytical Procedures: Methodology Legislative basis Directive 75/318/EEC as amended Date of first adoption December 1996
More informationTechnical updates medicines inspections: Finished Pharmaceutical Products (FPP)
Technical updates medicines inspections: Finished Pharmaceutical Products (FPP) Vimal Sachdeva, Technical Officer (Inspector) WHO Prequalification Team (PQT), WHO/HIS/EMP/RHT 20 Avenue Appia, CH - 1211,
More informationFusion AE. Analytical Method Development And Method Validation
Analytical Method Development And Method Validation Automated Experimentation Chemometric platform for analytical method development and validation. Auto-control of instrument parameters, external solvent
More informationc) Have personnel been appointed to supervise the production operations across all shifts in order to ensure the product quality?
Factory s Quality Assurance Ability 1 Responsibilities and Resources 1.1 Responsibilities a) Have the responsibilities and interrelation of various personnel involved in quality activities been defined?
More informationEUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 25 October 2005 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU
More informationData Integrity and Compliance With Drug CGMP Questions and Answers Guidance for Industry
Data Integrity and Compliance With Drug CGMP Questions and Answers Guidance for Industry U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research
More informationSIMATIC IT. SIMATIC IT R&D SUITE V7.1 Compliance Response ERES. Introduction 1. The Requirements in Short 2
Introduction 1 The Requirements in Short 2 SIMATIC IT Meeting the Requirements with SIMATIC IT R&D Suite V7.1 3 SIMATIC IT R&D SUITE V7.1 Evaluation List for SIMATIC IT R&D Suite V7.1 4 Product Information
More informationHow to Set Up and Manage Quality Control and Quality Assurance
How to Set Up and Manage Quality Control and Quality Assurance Myriam Visschedijk 1, *, Rik Hendriks 2 and Katrien Nuyts 3 1 TNO Quality of Life, The Netherlands 2 Johnson & Johnson Pharmaceutical Research
More informationSupplier Quality System Survey
Supplier Division Address Date: Quality Contact: Reports to: Title: Title: Phone Fax e-mail Plant size (ft 2 ): Union: Contract expires: Total Employment: Direct Labor: Shifts: QA employees: This report
More information